Drug Shortage Report for ODAN-INDOMETHACIN

Last updated on 2025-01-14 History
Report ID 205248
Drug Identification Number 02231800
Brand name ODAN-INDOMETHACIN
Common or Proper name Indomethacin Suppositories, USP
Company Name ODAN LABORATORIES LTD
Market Status MARKETED
Active Ingredient(s) INDOMETHACIN
Strength(s) 100MG
Dosage form(s) SUPPOSITORY
Route of administration RECTAL RECTAL
Packaging sizes (GTIN)

Click here to see a list of all reports for this drug.

(See additional packaging sizes)
Additional packaging sizes Boxes of 30
ATC code M01AB
ATC description ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2023-09-25
Estimated end date 2025-06-30
Actual end date
Shortage status Actual shortage
Updated date 2025-01-14
Company comments
Health Canada comments
Tier 3 Status No
Company contact information [email protected] Tel.: 1-800-387-9342 Fax: 1-800-329-6326

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v12 2025-01-14 French Compare
v11 2025-01-14 English Compare
v10 2024-11-01 French Compare
v9 2024-11-01 English Compare
v8 2024-10-02 French Compare
v7 2024-10-02 English Compare
v6 2024-04-11 French Compare
v5 2024-04-11 English Compare
v4 2024-01-22 French Compare
v3 2024-01-22 English Compare
v2 2023-09-26 French Compare
v1 2023-09-26 English Compare

Showing 1 to 12 of 12